Prelude Therapeutics Inc

• WILMINGTON, DE How do I update this listing?

Prelude Therapeutics is based out of Wilmington. Prelude Therapeutics Incorporated operates as a biopharmaceutical company. The Company develops and designs a pipeline of novel, orally bioavailable, and small molecule therapies that target key drivers of cancer cell growth. Prelude Therapeutics serves patients worldwide. The firm last filed a Form D notice of exempt offering of securities on 2020-08-28. The notice included securities offered of Equity

Create Alert

Contact Info

prelude therapeutics inc
200 POWDER MILL ROAD
WILMINGTON DE    19803
Business Phone: (302) 547-3768
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2020-08-28 D BIOTECHNOLOGY Equity 49,999,969 49,999,969 0
2019-06-17 D BIOTECHNOLOGY Equity 59,999,998 29,999,999 29,999,999
2018-08-17 D/A BIOTECHNOLOGY Equity 29,999,998 29,999,998 0
2017-10-20 D BIOTECHNOLOGY Equity 12,000,000 12,000,000 0
2016-07-11 D BIOTECHNOLOGY Equity 5,000,000 5,000,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ANDREW COMBS subscription required
    EXECUTIVE OFFICER
BRIAN PIPER subscription required
    EXECUTIVE OFFICER
CHRISTOPHER PIERCE subscription required
    EXECUTIVE OFFICER
DAVID BONITA subscription required
    DIRECTOR
DAVID MAURO subscription required
    EXECUTIVE OFFICER
DEBORAH MOROSINI subscription required
    EXECUTIVE OFFICER
JUAN LUENGO subscription required
    EXECUTIVE OFFICER
KELVIN NEU subscription required
    DIRECTOR
KRISHNA VADDI subscription required
    EXECUTIVE OFFICER DIRECTOR
MARDI C. DIER subscription required
    DIRECTOR
PAUL FRIEDMAN subscription required
    DIRECTOR
PEGGY SCHERLE subscription required
    EXECUTIVE OFFICER
VICTOR SANDOR subscription required
    DIRECTOR

Elevate your investments